Stay updated on Pembrolizumab in Biliary Tract Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Biliary Tract Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s displayed site revision updated from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T03:24:03.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record for a completed Phase 2 pembrolizumab trial in metastatic biliary tract cancer is displayed, with its design, eligibility criteria, outcome measures, and study dates.
    Difference
    37%
    Check dated 2026-11-11T02:16:23.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T01:12:39.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the footer revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:06:24.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-07T01:22:58.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with an error screen. This indicates access is blocked and the study information cannot be viewed.
    Difference
    16%
    Check dated 2026-09-23T01:15:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Biliary Tract Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.